GU Cancer

Australian data shows rapid but variable uptake of hypofractionated RT

Uptake of hypofractionated radiation therapy for nonmetastatic prostate cancer has increased dramatically in recent years with no differences in patient-reported outcomes. The increased uptake is consistent with 2018 international guidelines which achieved strong consensus for offering moderately hypofractionated RT across risk groups to patients choosing external beam radiation therapy. In data from 6,368 patients in ...

Already a member?

Login to keep reading.

© 2022 the limbic